MDxHealth
(NASDAQ) MDXH
MDxHealth Financials at a Glance
Market Cap
$25.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$171.32M
Net Income (TTM)
-$64.22M
EPS (TTM)
-$0.66
P/E Ratio
-0.75
Dividend
$0.00
Beta (Volatility)
13454.61 (High)
Dividend
$0.00
Beta (Volatility)
13454.61 (High)
Price
$0.49
Volume
289,029.369
Open
$0.50
Price
$0.49
Volume
289,029.369
Open
$0.50
Previous Close
$0.49
Daily Range
$0.48 - $0.52
52-Week Range
$0.40 - $5.33
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
13454.61 (High)
Price
$0.49
Volume
289,029.369
Open
$0.50
Previous Close
$0.49
Daily Range
$0.48 - $0.52
52-Week Range
$0.40 - $5.33
Estimated Earnings Date
Aug 13, 2026
MDXH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MDxHealth
Industry
Biotechnology
Sector
Health CareEmployees
364
CEO
Michael K. McGarrity
Website
www.mdxhealth.comHeadquarters
Herstal, WA 4040, BE
MDXH Financials
Key Financial Metrics (TTM)
Gross Margin
57.68%
Operating Margin
-16.59%
Net Income Margin
-32.17%
Return on Equity
402.97%
Return on Capital
-18.55%
Return on Assets
-17.67%
Earnings Yield
-1.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$25.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
51.36M
Volume
289.03K
Avg. Volume
796.16K
Financials (TTM)
Gross Profit
$102.02M
Operating Income
-$38.21M
EBITDA
-$21.09M
Operating Cash Flow
-$19.75M
Capital Expenditure
-$2.58M
Free Cash Flow
-$22.33M
Cash & ST Invst.
$29.03M
Total Debt
$95.11M
MDxHealth Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$54.67M
+41.1%
Gross Profit
$29.31M
+16.2%
Gross Margin
53.61%
N/A
Market Cap
$25.43MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$81.49K
N/A
Employees
312
N/A
Net Income
-$18.78M
+9.6%
EBITDA
-$6.74M
+60.5%
Quarterly Fundamentals
Total Cash
$29.03M
+29.7%
Total Debt
$95.11M
+130.5%
Accounts Receivable
$14.68M
+30.2%
Inventory
$6.74M
+142.6%
Long Term Debt
$93.22M
+138.1%
Short Term Debt
$1.90M
-10.6%
Return on Assets
-17.67%
N/A
Return on Invested Capital
-13.70%
N/A
Free Cash Flow
$324.00K
+102.4%
Operating Cash Flow
$378.00K
+103.2%